Eton Pharmaceuticals, Inc. (ETON) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 24.27M | 21.28M | 22.46M | 18.93M | 17.28M | 11.65M | 10.32M | 9.07M | 7.97M | 7.31M | 7.03M | 12M | 5.3M | 8.5M | 3.22M | 7.36M | 2.18M | 6.09M | 775K | 3.07M |
| Revenue Growth % | 40.41% | 82.72% | 117.54% | 108.6% | 116.95% | 59.26% | 46.9% | -24.36% | 50.19% | -13.94% | 118.33% | 63.05% | 143.75% | 39.47% | 315.35% | 139.91% | -81.71% | 7422.22% | 581.37% | 15235% |
| Cost of Goods Sold | 9.53M | 8.18M | 14.6M | 7M | 7.42M | 5.17M | 4.02M | 3.45M | 2.96M | 3.68M | 2.63M | 2.31M | 1.96M | 2.14M | 1.2M | 2.75M | 718K | 280K | 617K | 136K |
| COGS % of Revenue | 39.28% | 38.44% | 65.03% | 37% | 42.94% | 44.4% | 38.96% | 38% | 37.15% | 50.36% | 37.35% | 19.3% | 36.92% | 25.16% | 37.31% | 37.31% | 33% | 4.6% | 79.61% | 4.43% |
| Gross Profit | 14.73M | 13.1M | 7.86M | 11.92M | 9.86M | 6.48M | 6.3M | 5.63M | 5.01M | 3.63M | 4.4M | 9.68M | 3.35M | 6.36M | 2.02M | 4.61M | 1.46M | 5.81M | 158K | 2.93M |
| Gross Margin % | 60.72% | 61.56% | 34.97% | 63% | 57.06% | 55.6% | 61.04% | 62% | 62.85% | 49.64% | 62.65% | 80.7% | 63.08% | 74.84% | 62.69% | 62.69% | 67% | 95.4% | 20.39% | 95.57% |
| Gross Profit Growth % | 49.43% | 102.29% | 24.64% | 111.94% | 96.94% | 78.4% | 43.13% | -41.89% | 49.64% | -42.92% | 118.19% | 109.89% | 129.49% | 9.41% | 1177.22% | 57.39% | -85.85% | 2754.34% | 1029.41% | 36737.5% |
| Operating Expenses | 12.32M | 10.64M | 9.22M | 13.4M | 10.33M | 5.85M | 5.79M | 8.56M | 5.81M | 5.62M | 4.95M | 5.8M | 5.88M | 5.3M | 4.91M | 5.95M | 6.54M | 4.5M | 6M | 5.26M |
| OpEx % of Revenue | 50.77% | 49.98% | 41.04% | 70.79% | 59.78% | 50.2% | 56.11% | 94.35% | 72.9% | 76.89% | 70.45% | 48.34% | 110.86% | 62.34% | 152.63% | 80.91% | 300.78% | 73.84% | 774.84% | 171.37% |
| Selling, General & Admin | 10.45M | 8.86M | 8.11M | 9.69M | 9.17M | 6.72M | 5.29M | 5.59M | 5.16M | 4.58M | 4.34M | 4.67M | 5.34M | 4.35M | 4.17M | 5.26M | 4.93M | 3.82M | 3.33M | 3.27M |
| SG&A % of Revenue | 43.05% | 41.61% | 36.09% | 51.18% | 53.06% | 57.68% | 51.22% | 61.62% | 64.73% | 62.57% | 61.7% | 38.96% | 100.77% | 51.24% | 129.51% | 71.53% | 226.42% | 62.66% | 429.29% | 106.49% |
| Research & Development | 1.88M | 1.78M | 1.11M | 3.71M | 1.16M | -871K | 505K | 2.97M | 651K | 1.05M | 615K | 1.13M | 535K | 944K | 744K | 690K | 1.62M | 681K | 2.68M | 1.99M |
| R&D % of Revenue | 7.73% | 8.36% | 4.95% | 19.61% | 6.72% | -7.48% | 4.89% | 32.73% | 8.17% | 14.32% | 8.75% | 9.38% | 10.09% | 11.11% | 23.11% | 9.38% | 74.36% | 11.18% | 345.55% | 64.88% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 2.41M | 2.46M | -1.36M | -1.48M | -470K | 629K | 509K | -2.94M | -800K | -1.99M | -548K | 3.88M | -2.53M | 1.06M | -2.9M | -1.34M | -5.09M | 1.31M | -5.85M | -2.33M |
| Operating Margin % | 9.95% | 11.58% | -6.07% | -7.79% | -2.72% | 5.4% | 4.93% | -32.35% | -10.04% | -27.25% | -7.8% | 32.37% | -47.78% | 12.5% | -89.93% | -18.21% | -233.78% | 21.57% | -754.45% | -75.81% |
| Operating Income Growth % | 613.62% | 291.73% | -367.78% | 49.74% | 41.25% | 131.56% | 192.88% | -175.59% | 68.43% | -287.66% | 81.07% | 389.78% | 50.19% | -19.18% | 50.49% | 42.37% | -194.85% | 117.71% | 6.78% | 48.77% |
| EBITDA | 2.41M | 3.48M | -354K | -470K | 543K | 984K | 787K | -2.66M | -566K | -1.72M | -357K | 4.05M | -2.32M | 1.31M | -2.73M | -169K | -4.91M | 1.45M | -5.76M | -2.24M |
| EBITDA Margin % | 9.95% | 16.36% | -1.58% | -2.48% | 3.14% | 8.45% | 7.62% | -29.27% | -7.11% | -23.49% | -5.08% | 33.8% | -43.76% | 15.46% | -84.65% | -2.3% | -225.46% | 23.81% | -743.48% | -73.04% |
| EBITDA Growth % | 344.57% | 253.76% | -144.98% | 82.3% | 195.94% | 157.28% | 320.45% | -165.5% | 75.61% | -230.75% | 86.9% | 2499.41% | 52.69% | -9.44% | 52.71% | 92.46% | -188.91% | 119.99% | 5.66% | 48.79% |
| D&A (Non-Cash Add-back) | 0 | 1.02M | 1.01M | 1M | 1.01M | 355K | 278K | 279K | 234K | 275K | 191K | 172K | 213K | 252K | 170K | 1.17M | 181K | 137K | 85K | 85K |
| EBIT | 2.41M | 2.47M | -743K | -1.48M | -470K | 629K | 509K | -2.94M | -800K | -2.79M | -548K | 4.68M | -2.53M | 1.06M | -2.9M | -1.34M | -5.09M | 1.31M | -5.85M | -1.78M |
| Net Interest Income | 840K | -1.21M | -1.21M | -1.2M | -1.16M | 0 | -8K | -52K | -11K | -361K | -31K | -124K | -126K | -256K | -150K | -218K | -243K | -275K | -247K | -237K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -840K | 1.21M | 1.21M | 1.2M | 1.16M | 0 | 8K | 52K | 11K | 361K | 31K | 124K | 126K | 256K | 150K | 218K | 243K | 275K | 247K | 237K |
| Other Income/Expense | -840K | -1.05M | -592K | -1.04M | -1.03M | -1.14M | -8K | -52K | -11K | -16K | -31K | 676K | -126K | -150K | -150K | -218K | -243K | -275K | -247K | 309K |
| Pretax Income | 1.57M | 1.41M | -1.96M | -2.52M | -1.5M | -511K | 501K | -2.99M | -811K | -2.01M | -579K | 4.56M | -2.66M | 912K | -3.04M | -1.56M | -5.33M | 1.04M | -6.09M | -2.02M |
| Pretax Margin % | 6.49% | 6.64% | -8.7% | -13.31% | -8.67% | -4.39% | 4.85% | -32.92% | -10.18% | -27.47% | -8.24% | 38% | -50.15% | 10.73% | -94.59% | -21.17% | -244.94% | 17.05% | -786.32% | -65.73% |
| Income Tax | 20K | -69K | -28K | 66K | 74K | 87K | -126K | 54K | 0 | 247K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1.27% | -4.88% | 1.43% | -2.62% | -4.94% | -17.03% | -25.15% | -1.81% | 0% | -12.29% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 1.55M | 1.48M | -1.93M | -2.58M | -1.57M | -598K | 627K | -3.04M | -811K | -2.26M | -579K | 4.56M | -2.66M | 912K | -3.04M | -1.56M | -5.33M | 1.04M | -6.09M | -2.02M |
| Net Margin % | 6.4% | 6.97% | -8.58% | -13.66% | -9.1% | -5.13% | 6.07% | -33.51% | -10.18% | -30.85% | -8.24% | 38% | -50.15% | 10.73% | -94.59% | -21.17% | -244.94% | 17.05% | -786.32% | -65.73% |
| Net Income Growth % | 198.86% | 347.99% | -407.34% | 15% | -93.83% | 73.49% | 208.29% | -166.7% | 69.51% | -347.37% | 80.99% | 392.62% | 50.09% | -12.22% | 50.03% | 22.72% | -204.18% | 113.52% | 6.3% | 57.38% |
| Net Income (Continuing) | 1.55M | 1.48M | -1.93M | -2.58M | -1.57M | -598K | 627K | -3.04M | -811K | -2.26M | -579K | 4.56M | -2.66M | 912K | -3.04M | -1.56M | -5.33M | 1.04M | -6.09M | -2.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.05 | 0.05 | -0.07 | -0.10 | -0.06 | -0.02 | 0.02 | -0.12 | -0.03 | -0.09 | -0.02 | 0.18 | -0.11 | 0.04 | -0.13 | -0.06 | -0.22 | 0.04 | -0.24 | -0.08 |
| EPS Growth % | 185.47% | 338.43% | -396.61% | 19.92% | -85.71% | 73.86% | 204.89% | -166.67% | 71.36% | -319% | 82.69% | 390.32% | 50% | 0% | 45.83% | 22.5% | -215.79% | 112.5% | 22.58% | 65.22% |
| EPS (Basic) | 0.06 | 0.06 | -0.07 | -0.10 | -0.06 | -0.02 | 0.02 | -0.12 | -0.03 | -0.09 | -0.02 | 0.18 | -0.11 | 0.04 | -0.13 | -0.06 | -0.22 | 0.04 | -0.24 | -0.08 |
| Diluted Shares Outstanding | 31.55M | 26.91M | 26.89M | 26.89M | 26.89M | 26.14M | 26.55M | 25.78M | 25.76M | 25.74M | 25.72M | 25.98M | 25.52M | 25.69M | 25.36M | 25.13M | 25.3M | 25.96M | 25.28M | 25.21M |
| Basic Shares Outstanding | 27.29M | 26.91M | 26.89M | 26.89M | 26.89M | 26.14M | 25.9M | 25.78M | 25.76M | 25.74M | 25.72M | 25.59M | 25.52M | 25.38M | 25.36M | 25.13M | 25.3M | 25.29M | 25.28M | 25.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |